- Home
- FMAC vs QTRX Comparison
FMAC vs QTRX Comparison
Compare FMAC & QTRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FMAC | QTRX |
|---|---|---|
| Founded | 2025 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Blank Checks | Biotechnology: Laboratory Analytical Instruments |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | N/A | 160.0M |
| IPO Year | 2025 | 2017 |
Fundamental Metrics
Financial Performance| Metric | FMAC | QTRX |
|---|---|---|
| Price | $10.13 | $2.84 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $3.17 |
| AVG Volume (30 Days) | 6.7K | ★ 503.8K |
| Earning Date | N/A | 11-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $37,632,000.00 |
| Revenue This Year | N/A | $3.21 |
| Revenue Next Year | N/A | $9.96 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 64.52 |
| 52 Week Low | $9.95 | $2.15 |
| 52 Week High | $10.13 | $8.77 |
Technical Indicators
Market Signals| Indicator | FMAC | QTRX |
|---|---|---|
| Relative Strength Index (RSI) | 64.54 | 41.99 |
| Support Level | $10.01 | $2.34 |
| Resistance Level | N/A | $3.99 |
| Average True Range (ATR) | 0.00 | 0.23 |
| MACD | 0.00 | -0.06 |
| Stochastic Oscillator | 100.00 | 13.03 |
Price Performance
Historical ComparisonAbout FMAC Future Money Acquisition Corporation Ordinary Shares
Future Money Acquisition Corp is a blank check company formed for the purpose of entering into a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses or entities.
About QTRX Quanterix Corporation
Quanterix Corp is a life sciences company accelerating biomarker breakthroughs from discovery to diagnostics using ultra-sensitive translational research and spatial biology instruments, consumables, and services. The company sells proprietary instruments and related consumables to research laboratories, contract research organizations (CROs), academic institutions, and bio-pharmaceutical companies, and provides contract research services and clinical laboratory testing services, including four Laboratory Developed Tests (LDTs), through its Accelerator Laboratory. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, and SP-X Imaging and Analysis System. Geographically, it operates in North America, EMEA, and the Asia Pacific.